![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 7
2022
Hübner, Hanna; Haeberle, Lothar; Müller, Volkmar; Schrader, Iris; Lorenz, Ralf; Forstbauer, Helmut; Fink, Visnja; Schochter, Fabienne; Bekes, Inga; Mahner, Sven; Jueckstock, Julia; Nabieva, Naiba; Schneeweiss, Andreas; Tesch, Hans; Brucker, Sara Y.; Blohmer, Jens-Uwe; Fehm, Tanja N.; Heinrich, Georg; Rezai, Mahdi; Beckmann, Matthias W.; Fasching, Peter A.; Janni, Wolfgang und Rack, Brigitte
(2022):
MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients.
In: Cancers, Bd. 14, Nr. 7, 1721
Trapp, Elisabeth K.; Fasching, Peter A.; Fehm, Tanja; Schneeweiss, Andreas; Mueller, Volkmar; Harbeck, Nadia; Lorenz, Ralf; Schumacher, Claudia; Heinrich, Georg; Schochter, Fabienne; de Gregorio, Amelie; Tzschaschel, Marie; Rack, Brigitte; Janni, Wolfgang und Friedl, Thomas W. P.
(2022):
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
In: Cancers, Bd. 14, Nr. 16, 3949
2021
Friedl, Thomas W. P.; Fehm, Tanja; Mueller, Volkmar; Lichtenegger, Werner; Blohmer, Jens; Lorenz, Ralf; Forstbauer, Helmut; Fink, Visnja; Bekes, Inga; Huober, Jens; Jueckstock, Julia; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y.; Heinrich, Georg; Haeberle, Lothar; Fasching, Peter A.; Beckmann, Matthias W.; Coleman, Robert E.; Janni, Wolfgang und Rack, Brigitte
(2021):
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment A Phase 3 Randomized Clinical Trial.
In: Jama Oncology, Bd. 7, Nr. 8: S. 1149-1157
2020
de Gregorio, Amelie; Haberle, Lothar; Fasching, Peter A.; Müller, Volkmar; Schrader, Iris; Lorenz, Ralf; Forstbauer, Helmut; Friedl, Thomas W. P.; Bauer, Emanuel; de Gregorio, Nikolaus; Deniz, Miriam; Fink, Visnja; Bekes, Inga; Andergassen, Ulrich; Schneeweiss, Andreas; Tesch, Hans; Mahner, Sven; Brucker, Sara Y.; Blohmer, Jens-Uwe; Fehm, Tanja N.; Heinrich, Georg; Lato, Krisztian; Beckmann, Matthias W.; Rack, Brigitte und Janni, Wolfgang
(2020):
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial.
In: Breast Cancer Research, Bd. 22, Nr. 1, 111
2017
Fasching, Peter A.; Häberle, Lothar; Rack, Brigitte; Li, Liang; Hein, Alexander; Ekici, Arif B.; Reis, Andre; Lux, Michael P.; Cunningham, Julie M.; Rübner, Matthias; Jenkins, Gergory; Fridley, Brooke; Schneeweiss, Andreas; Tesch, Hans; Lichtenegger, Werner; Fehm, Tanja; Heinrich, Georg; Rezai, Mahdi; Beckmann, Matthias W.; Janni, Wolfgang; Weinshilboum, Richard M. und Wang, Liewei
(2017):
Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity.
In: Oncotarget, Bd. 8, Nr. 44: S. 78133-78143
Schramm, Amelie; Schochter, Fabienne; Friedl, Thomas W. P.; Greqorio, Nikolaus de; Andergassen, Ulrich; Alunni-Fabbroni, Marianna; Trapp, Elisabeth; Jaeger, Bernadette; Heinrich, Georg; Camara, Oumar; Decker, Thomas; Ober, Angelika; Mahner, Sven; Fehm, Tanja N.; Pantel, Klaus; Fasching, Peter A.; Schneeweiss, Andreas; Janni, Wolfgang und Rack, Brigitte K.
(2017):
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
In: Clinical Breast Cancer, Bd. 17, Nr. 4: S. 279-285
2013
Harbeck, Nadia; Beckmann, Matthias W.; Rody, Achim; Schneeweiss, Andreas; Müller, Volkmar; Fehm, Tanja; Marschner, Norbert; Gluz, Oleg; Schrader, Iris; Heinrich, Georg; Untch, Michael und Jackisch, Christian
(2013):
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer.
In: Breast Care, Nr. 1: S. 49-55
[PDF, 954kB]